Inputs: momentum, trendVelocity
Momentum 36/100 with trend velocity 9/100 — trend is rolling over.
Not financial advice. MarketPicks.ai is an impersonal research tool. AI output can be wrong. Investing involves risk of loss. Do your own research and consult a licensed professional. Full disclaimer.
Prediction result · Ensemble engineUpdated 5:38 AM
ImmunityBio, Inc. (IBRX) is trading at $8.29, down 5.15% since the previous close and +0.85% over the past week. Price sits below its 50-day average by 4.79%, with price momentum at 36/100 and trend velocity at 9/100. Sentiment across 7 recent headlines reads net constructive at 58/100. Volatility risk is elevated (100/100) and the stock is 60% of the way up its 52-week range. The weighted factor score lands at 34/100 — a bearish signal. Research only, not investment advice.
ImmunityBio, Inc.
Signals are model output from public data, not personalized investment advice.
Invalidate on a reclaim of the session offer, catalyst relief, or model edge flipping bullish.
AI Signal
Full public-market mode: chart history, quote, and news inputs were available.
Chart feed
Cron market chart feed
Quote/history
Six-month public chart history loaded.
News feed
7 relevant headlines found.
Signal inputs
Technical factors and news sentiment evaluated across multiple signal inputs.
Historical Modeling: Visualized ranges are mathematically derived from historic volatility metrics, corporate filings, and option-implied volume profiles. They represent statistical points of interest for research purposes, not financial execution commands or advice.
Why It Matters
ImmunityBio, Inc. (IBRX) is trading at $8.29, down 5.15% since the previous close and +0.85% over the past week. Price sits below its 50-day average by 4.79%, with price momentum at 36/100 and trend velocity at 9/100. Sentiment across 7 recent headlines reads net constructive at 58/100. Volatility risk is elevated (100/100) and the stock is 60% of the way up its 52-week range. The weighted factor score lands at 34/100 — a bearish signal. Research only, not investment advice.
Analyst Engine · Specialist model ensemble
Weighted factor score across 16 signal inputs evaluating 9 features: momentum, news, volume, volatility, range, sentiment divergence, trend structure, and oscillator. Consensus and weighting applied. Each specialist bot inspects a different slice of the feature set, casts a directional vote, and contributes a confidence weight to the final score.
Momentum 36/100 with trend velocity 9/100 — trend is rolling over.
Sentiment 58/100 + price -5.2% are both mid-range.
Volume read 15/100 with price drift -5.2% — no clear footprint.
High volatility (100/100) without momentum support — wide path, more downside variance.
Mid-range positioning — no edge from range alone.
Sentiment 58/100 vs week change 0.8% are in agreement — no divergence edge.
Price within 4.8% of the 50d SMA — no clear structural read.
Composite oscillator at 23 — washed-out zone, mean-reversion candidate.
Momentum 36/100 is not strong enough to confirm a breakout.
News 58/100 and weekly change 0.8% do not create a clean follow-through read.
Volume 15/100 is quiet and trend velocity is weak — move lacks sponsorship.
Very high volatility (100/100) with weak momentum is a rough setup for holders.
Range position 60% is too middle-of-the-road to matter.
Sentiment 58/100 and momentum 36/100 are not aligned enough for a clean read.
Price is still under the 50d SMA and the trend has not reclaimed control.
Oscillator at 23 with weekly stabilization is a rebound setup.
Why the ensemble agrees
Counter-trees
Headline titles only, from the publisher named on each card. Each links to the original story.
10/30/2026, 7:55:14 PM
10/27/2026, 7:14:51 AM
10/30/2026, 5:16:56 AM
10/27/2026, 7:16:41 AM
10/27/2026, 4:03:19 PM
Key stats
Source: Nasdaq public quote data. Research only.
Earnings Intelligence
Next
Nov 3, 2026
Estimate
$-0.08
Actual
$-0.08
As of Nov 2, 12:38 AM ET, the ensemble reads bearish on IBRX — bearish — 5 of 16 bots down, with 2 bull, 5 bear and 9 hold votes from 16 specialist bots. Research only, not investment advice.
IBRX was $8.29 on the latest quote (Nov 2, 12:38 AM ET), -5.15% since the previous close. Quotes can be delayed.
Scores run from 0 to 100, with 50 neutral. IBRX shows momentum 36/100, trend velocity 9/100 and volatility risk 100/100, with news sentiment at 58/100.
Not financial advice. MarketPicks.ai is an impersonal research tool. AI output can be wrong. Investing involves risk of loss. Do your own research and consult a licensed professional. Full disclaimer.